Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 497M | 4% |
| Gross Profit | 73M | 26.5% |
| Cost of Revenue | 423M | 12% |
| Operating expense | 98M | 11.5% |
| Net Income | -24M | 130.4% |
| EBITDA | -24M | 135.4% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 560M | 2.7% |
| Total Liabilities | 219M | 5.2% |
| Total Equity | 341M | 0.9% |
| Shares Outstanding | 513M | 0.8% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 12M | 123.8% |
| Cash from investing | -5.4M | 115.3% |
| Cash from financing | -5.3M | 32.1% |
EPS
Financial Highlights for Clover Health in Q3 '25
Clover Health reported a revenue of 497M, which is a 4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 73M, marking a -26.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 423M, a 12% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 98M, showing a -11.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -24M, showing a -130.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -24M, showing a -135.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Clover Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures. A decline in EBITDA signals potential operational challenges or increased costs.
